21 March 2016 – Intel Capital, Qualcomm, Spoonrocket, Corvus Pharmaceuticals, Hutchison China MediTech, GenomeDx, LendInvest, DouyuTV, Cainiao and more
http://media.blubrry.com/globalventuringreview/s3-eu-west-1.amazonaws.com/inearproduction/podcasts/globalventuringreview/episodes/07-globalventuringreview-21mar2016.mp3
Intel Capital is reportedly looking to sell up to $1bn worth of its venture assets.
Qualcomm meanwhile looks to have scored a major exit after General Motors agreed to buy driverless vehicle technology developer Cruise Automation in a deal reportedly sized north of $1bn. Cruise, which was founded in 2013, had disclosed only $18m in debt and equity financing.
Just days after announcing it was shutting down, VC-backed SpoonRocket has been acquired by iFood, a delivery service in Latin America that has raised more than $60m from Brazil-based Movile Internet and Warehouse Investimentos, among others.
Corvus Pharmaceuticals, an oncology therapy developer backed by Roche and Novo, filed for a $115m IPO in January but has subsequently set a range between $70m and $80m. It had raised $108m in venture capital over the past two years.
Hutchison China MediTech (Chi-Med), a China-based healthcare group backed by conglomerate Mitsui, raised $101.3m when it floated on Nasdaq yesterday.
GenomeDx released a prostate cancer testing product last week and has followed it with $25.4m in series C funding, according to an SEC filing. The funding represents the first to be publicly disclosed – in terms of size anyway – for the company, which is backed by investors including Merck's Global Health Innovation fund.
Having received £22m from Beijing Kunlun in June last year, LendInvest raised £17m from VC firm Atomico, bringing its total debt and equity financing to more than £200m.
DouyuTV, a streaming service focused on the livestreaming of video games, has raised $100m in a series B round led by Tencent, which reportedly provided more than $60m.
Alibaba's financial services affiliate Ant Financial is said to be raising money at a $60bn valuation but its logistics spinout Cainiao isn't doing too badly either, having raised a reported $1.54bn in a round that values it at $7.7bn.
Diversified conglomerate HNA Group has agreed to invest RMB1.2bn ($185m) in online sports streaming platform Le Sports as part of a series B round that could reach $1.08bn, according to a regulatory filing.
Ring, a US-based smart doorbell developer backed by insurance provider American Family Insurance and home builder JF Shea, has raised $61.2m in a series C round featuring Kleiner Perkins Caufield & Byers.
University College London cancer treatment spinout Autolus licences additional technology from the university as it raises $57m in its series B round.
Biotechnology startup Aprea, a spinout of Karolinska Institute that is backed by a range of public investors, has raised the biggest round for a Sweden-based life sciences company in a decade.
QB3, University of California's research institute and life science accelerator, loses its associate director as Douglas Crawford steps down.
Author Global Venturing ReviewPosted on March 21, 2016 March 19, 2016 Tags "Corvus Pharmaceuticals", "Douglas Crawford", "HNA Group", "Hutchison China MediTech", "Intel Capital", "Karolinska Institute", "Kleiner Perkins Caufield & Byers", "Le Sports", "University College London", Aprea, Autolus, Cainiao, corporate venturing, DouyuTV, funding, GenomeDx, government venturing, investment, IPO, LendInvest, QB3, Qualcomm, Ring, Spoonrocket, university venturing, venture capital
Previous Previous post: 14 March 2016 – Ant Financial, Flipkart, WeWork, Astroscale, Precision Ocular, Replay Technologies, Lasergen, Stanford University and more
Next Next post: 04 April 2016 – LeSports, Yiguo, Betterment, Jucero, Emulate, M-Files, IDG Ventures India, IBM Ventures, Siemens Venture Capital, Imperial Innovations, Oakland University and more